162 related articles for article (PubMed ID: 32963909)
1. Clinicopathological Characteristics and Short-Term Survival Analyses of Cutaneous Malignant Melanoma.
Ullah F; Jamshed M; Shakeel O; Khalid U; Khan R; Dhanani R; Mansoor R; Ullah S; Hussain R
Cureus; 2020 Aug; 12(8):e9868. PubMed ID: 32963909
[TBL] [Abstract][Full Text] [Related]
2. Clinico-pathological Characteristics of Cutaneous Malignant Melanoma in Pakistan.
Khan RS; Shakeel O; Bhatti AF; Hussain R
J Coll Physicians Surg Pak; 2020 Nov; 30(11):1197-1200. PubMed ID: 33222740
[TBL] [Abstract][Full Text] [Related]
3. Malignant Melanoma of the Female Genital Tract: Experience of an Oncology Center in Pakistan.
Shakeel O; Ullah F; Khalid N; Ali SI; Batool S; Amjad A; Anwer AW; Ali H; Zafar H; Syed AA
Cureus; 2020 Jun; 12(6):e8484. PubMed ID: 32642388
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.
Ghazawi FM; Cyr J; Darwich R; Le M; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Am Acad Dermatol; 2019 Feb; 80(2):448-459. PubMed ID: 30092328
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
7. Patients' Characteristics, Histopathological Findings, and Tumor Stage in Different Types of Malignant Melanoma: A Retrospective Multicenter Study.
Farahmand AM; Ehsani AH; Mirzaei M; Mohsenian M; Ghanadan A
Acta Med Iran; 2017 May; 55(5):316-323. PubMed ID: 28724272
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous malignant melanoma in central iran: a 20-year study.
Noorbala MT; Mohammadi S; Noorbala M
Iran Red Crescent Med J; 2013 Aug; 15(8):690-4. PubMed ID: 24578836
[TBL] [Abstract][Full Text] [Related]
9. Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs.
Buja A; Rugge M; Damiani G; Zorzi M; De Toni C; Vecchiato A; Del Fiore P; Spina R; Baldo V; Brazzale AR; Rossi CR; Mocellin S
J Womens Health (Larchmt); 2022 Jul; 31(7):1012-1019. PubMed ID: 35076310
[No Abstract] [Full Text] [Related]
10. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
[TBL] [Abstract][Full Text] [Related]
11. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma.
Chen H; Takahara M; Oba J; Xie L; Chiba T; Takeuchi S; Tu Y; Nakahara T; Uchi H; Moroi Y; Furue M
J Dermatol Sci; 2011 Oct; 64(1):39-44. PubMed ID: 21767935
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features and prognostic factors in patients with non-cutaneous malignant melanoma: a single-center retrospective study of 71 cases.
Zhu H; Dong D; Li F; Liu D; Wang L; Fu J; Song L; Xu G
Int J Dermatol; 2015 Dec; 54(12):1390-5. PubMed ID: 26016703
[TBL] [Abstract][Full Text] [Related]
14. Worldwide cutaneous malignant melanoma incidences analyzed by sex, age, and skin type over time (1955-2007): Is HPV infection of androgenic hair follicular melanocytes a risk factor for developing melanoma exclusively in people of European-ancestry?
Merrill SJ; Subramanian M; Godar DE
Dermatoendocrinol; 2016; 8(1):e1215391. PubMed ID: 27588159
[TBL] [Abstract][Full Text] [Related]
15. Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005.
Pruthi DK; Guilfoyle R; Nugent Z; Wiseman MC; Demers AA
J Am Acad Dermatol; 2009 Jul; 61(1):44-50. PubMed ID: 19395122
[TBL] [Abstract][Full Text] [Related]
16. Serum Total 25-Hydroxyvitamin D Levels in Patients With Cutaneous Malignant Melanoma: A Case-Control Study in a Low-Risk Southern European Population.
Befon A; Katoulis AC; Georgala S; Katsampas A; Chardalia V; Melpidou A; Tzanetakou V; Chasapi V; Polydorou D; Desinioti C; Plaka M; Rigopoulos D; Stratigos AJ
Dermatol Pract Concept; 2020; 10(1):e2020010. PubMed ID: 31921497
[TBL] [Abstract][Full Text] [Related]
17. Prognostic risk factors of first recurrence in patients with primary stages I-II cutaneous malignant melanoma - from the population-based Swedish melanoma register.
Lyth J; Falk M; Maroti M; Eriksson H; Ingvar C
J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1468-1474. PubMed ID: 28419674
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
[TBL] [Abstract][Full Text] [Related]
19. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
[TBL] [Abstract][Full Text] [Related]
20. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
